Godavari Biorefineries Limited has informed the Exchange regarding Board meeting held on August 07, 2025.
GODAVARIB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godavari Biorefineries' board, which met on August 7, 2025, approved unaudited consolidated Q1 FY26 results showing total income of ₹53,397 lakhs (vs ₹52,527 lakhs in Q1 FY25) but a net loss of ₹1,602 lakhs (vs ₹2,611 lakhs loss a year ago), with EPS at ₹(3.13). Segment-wise, Sugar (₹21,981 lakhs) and Distillery (₹20,700 lakhs) led revenue, while Sugar and Cogeneration segments posted operating losses; Bio-based Chemicals and Distillery remained profitable at the operating level. The board appointed two new Non-Executive Independent Directors - Nandan Dhananjay Mehta (TCS corporate affairs background) and Sean Edward Reagan (former Dow/Garrett Motion finance executive) - each for a five-year term, and re-appointed Hemant Luthra for a second three-year term as Independent Director from October 30, 2025. Shreyans Ganga was appointed as Deputy CFO and Key Managerial Personnel effective August 7, 2025, having previously served as GM (Accounts and Finance). The 70th AGM was scheduled for September 30, 2025 via video conferencing.
The quarter showed a narrower loss compared to last year, but the company remains in the red at the bottom line, which may weigh on near-term sentiment despite revenue stability. The addition of two seasoned global finance professionals to the board and a new Deputy CFO signals governance strengthening, though shareholders will look for a return to profitability in coming quarters.